Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

for notice by other immune cells called T cells. This programs the T cell to launch an immune attack the next time it encounters the antigen. But the researchers showed that when the tolerogenic ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how specific immune cells, known as T cells, are activated and proliferate ...

Finally, CD8 + T cell-mediated antitumor immunity to promote immune escape was suppressed. Wondering whether blockade of the ...

The following is a summary of “A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,” published in the April ...

Once reprogrammed, these TAMs suppress cancer-fighting CD8 + T cells, the immune system's ... may be exploited by other tumors as well to escape immune surveillance. This discovery marks a ...

which are T cells that make up the killing machinery of the immune system, says Pomerantz. The scientists say their experiments show that QRICH1 acts as a partial brake that regulates T-cell ...

An Indian biotech start-up led by a Kashmir scientist has a patented, 3rd-generation CAR-T therapy that targets cancer ...

This important work presents a stochastic branching process model of tumour-immune coevolution, incorporating stochastic antigenic mutation accumulation and escape within the cancer cell population.

As a result, dendritic cells activate T cells and prime them to target disease. The mechanism by which dendritic cells process and express proteins specific to infection for immune cell activation ...